Strong impact of pre-HSCT recipient/donor cytomegalovirus (CMV) serostatus on survival of allo-HSCT

Aguirre, L; Lombardi, C; Ondarra, L; Montes, M; Artola, T; Ferreiro, J; Araiz, M; Esteban, B; Pizarro, MJ; Vallejo, C

BONE MARROW TRANSPLANTATION, 2019; 54 (): 436